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Evidence that tolerance induction was correlated withThe Scripps Research Institute
the maturational status of the B cell rather than the formLa Jolla, California 92037
of the antigen came from in vitro studies of hapten-
specific B cells. These studies demonstrated that hap-
ten-specific immature B cells could be tolerized equallyIntroduction
well by hapten complexed to either nonimmunogenic or
highly immunogenic carriers as long as the carrier wasThe “clonal selection hypothesis” evolved largely as a
not recognized by available helper T cells (Th) (Metcalfmeans to account for “the absence of immunological
and Klinman, 1976). These studies also suggested thatresponse to self constituents and the related phenom-
tolerance susceptibility was primarily dependent on theena of immunological tolerance” (Burnet, 1957). Thus,
maturational status of B cell clones rather than the agethe presence of a cell surface molecule that reflected
of the animal, since, even though the proportion of toler-the unique specificity of each cell provided a convenient
ance-susceptible splenic B cells decreased to less thanmeans, not only for selective antigenic stimulation, but
10% after the first week after birth, 25% of bone marrowalso for the selective elimination of cells by self-antigen
B cells remained tolerance susceptible throughout the(Burnet, 1957, 1959; Talmage, 1957). The initial formula-
lifetime of the animal. It is noteworthy that there aretion of the hypothesis assumed that the so-called ran-
several differences both in antigen responsiveness ofdomization of specificities, and thus, tolerance suscepti-
tolerance-susceptible bone marrow versus neonatalbility, would be limited to the perinatal period. However,
cells and in the parameters of their susceptibility tocontemporaneous refinements of the theory appreci-
tolerance induction (Klinman et al., 1976; Metcalf andated the need to account for the lifelong generation of
Klinman, 1977). In particular, neonatal B cells are toler-novel specificities and that “susceptibility to the induc-
ance susceptible for several days during which B celltion and maintenance of tolerance by the timely intro-
clones may be expanding. Bone marrow cells, on theduction of the antigen may have only a coincidental
other hand, cease dividing prior to becoming tolerancerelationship to the immunological incompetence of the
susceptible and remain tolerance susceptible for only
newborn animal” (Lederberg, 1959). The clonal selection
several hours. Subsequent studies have documented
hypothesis has endured as a unifying framework for
several other differences between newly generating
understanding self–nonself-discrimination in spite of the
neonatal versus adult bone marrow B cells (Landreth et
relative paucity of information concerning both the cellu-
al., 1983; Zharhary etal., 1984; Oltz et al.,1992); however,
lar and molecular basis of the immune response avail-
differences in their susceptibility to tolerance induction
able at the time it was formulated. Not surprisingly, sub-
have received little attention in recent years.
sequent research has identified layers of complexity in
Direct evidence that the maturational status of B cell
immune responsiveness, including the participation of
clones was crucial to tolerance susceptibility ultimately
two very different cell types, T and B cells. Furthermore,
came from analyses of individual B cell clones in neona-
the parameters of tolerance induction of T versus B cells
tal mice. The B cell repertoire of neonates is highly re-
were shown to be quite distinct, which shattered any stricted and B cells of identifiable clonotypes recur in a
possibility of a unifying hypothesis for tolerance induc- time-ordered fashion (Klinman and Press, 1975; Sigal et
tion (Taylor, 1969; Weigle et al., 1974; Howard and Mit- al., 1976; Cancro et al., 1979). It was possible, therefore,
chison, 1975). to demonstrate that cells of early arising clonotypes
passed through the window of tolerance susceptibility
Refining the “Clonal Selection Hypothesis” earlier than later arising clonotypes (Metcalf et al., 1977;
In spite of the aforementioned complexities, the major Denis and Klinman, 1983). These findings confirmed the
premise of the clonal selection hypothesis, that imma- expectation that tolerance susceptibility should be cor-
ture B cells, but not mature cells, are susceptible to related to the maturational status of each developing B
tolerance induction, has stood the test of time (Metcalf cell clone, rather than to the age of the mouse even
and Klinman, 1976, 1977; Cambier et al., 1976; Stocker, during neonatal development.
1977; Szewczuk and Siskind, 1977; Teale et al., 1979; The Tolerance Signal Applies to Immature
Scott et al., 1979; Etlinger and Chiller, 1979; Nossal and but not Mature B Cells
Pike, 1980; Klinman et al., 1981; DeFranco et al., 1982; The initial demonstration that tolerance is the result of
Nossal, 1983; Yellen et al., 1991; Scott, 1993; Monroe, an active signaling process came from in vitro studies
1996). Furthermore, numerous subsequent findings wherein tolerance induction was blocked by the addition
have been consistent with and further defined the funda- of inhibitors of energy metabolism, and protein or RNA
mental expectations that tolerance induction should be synthesis (Teale and Klinman, 1984). Subsequent stud-
far more dependent on the maturational status of the B ies demonstrated differences in the inistol phospholipid
cell per se than on either the age of the animal or the signaling pathway, the expression of fyn and fgr src
form of the antigen used to induce tolerance, and should family tyrosine kinases (Yellen et al., 1991; Wechsler
depend on a signal induction cascade that is applicable and Monroe, 1995; Monroe, 1996), and the induction of
apoptosis in immature versus mature B cells (Yellen etto immature but not mature B cells.
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al., 1991; Wechsler and Monroe, 1995; Norvell et al., experimental protocols required over 24 hr for cell isola-
1995; Monroe, 1996). These findings have recently been tion, homing, tolerance induction, and stimulation.
reviewed along with potential differences in the trig- These studies, therefore, were incapable of a precise
gering of surface (s)IgD2 versus sIgD1 cells and have identification of the maturational stage or stages where-
led to the conclusion that “it is the stage of B cell devel- in B cells are especially tolerance susceptible. Because
opment and not the ability to engage T cell help, the B cells responsive to any given antigen are relatively
presence of positive or negative autocrine factors, or rare, in vivo assessments based on clonal elimination
the relative expression of IgD that is critically important have been difficult and polyclonal tolerogens such as
in determining the fate of the B cell upon Ag encounter” anti-immunoglobulin antibodies, are likely to mimic anti-
and that “differential responsiveness and tolerance sus- gens poorly and have yielded conflicting results (Lawton
ceptibility is due to intrinsic differences in B cell receptor et al., 1972; Scott et al., 1979; Carsetti et al., 1993; Mon-
signal transduction” (Monroe, 1996). Nonetheless, a di- roe, 1996). The use of immunoglobulin transgenic mice
rect correlation between differences in the intracellular has enabled considerable progress in both detailing the
events triggered in immature versus mature B cells and parameters of B cell tolerance induction and identifying
the selective inactivation of immature cells has yet to maturational stages wherein cells are tolerance suscep-
be demonstrated. tible. These studies have taken one of three general
forms wherein the transgene encodes an immunoglobu-
Modifying the Clonal Selection Hypothesis lin that either recognizes a bona fide self-antigen (Nem-
Beyond the fundamental premise that immature B cells azee and Burki, 1989; Erikson et al., 1991; Okamoto et
should be uniquely tolerance susceptible, numerous al., 1992), a “pseudo-self” antigen encoded by a second
findings concerning B cell tolerance were unanticipated transgene (Goodnow et al., 1988, 1991; Basten et al.,
and often contradicted the expectations of the clonal 1991, Goodnow, 1992), or an antigen that is injected at
selection hypothesis. These findings and the modifica- high concentrations (Kenny et al., 1989; Carsetti et al.,
tions they require in the clonal selection hypothesis are 1993).
discussed below. Because thevast majorityof B cells in immunoglobulin
Immature B Cells Can Be Both Tolerized transgenic mice share receptors and antigenic specific-
and Antigenically Stimulated ity, it has been relatively easy to demonstrate tolerogen-
The inability to generate antibody responses from B
induced B cell elimination. Indeed, these studies initially
cells of early neonates either in vivo or in vitro made it
served as compelling confirmation of the importance
difficult to test directly the hypothesis that immature B
of tolerance in shaping the B cell repertoire. However,
cells were especially tolerance susceptible. However, in
transgenic mice may not represent an ideal model for
the early 1970s, the use of the fragment culture tech-
normal B cell physiology, since B cell development is
nique made it possible to stimulate fetal and neonatal
accelerated in immunoglobulin transgenic mice andB cells in vitro (Press and Klinman, 1974; Metcalf and
cells of these mice do not have to compete with theKlinman, 1976). With this technique, lethally irradiated
vast repertoire of B cells characteristic of conventionalmice, previously primed with carrier proteins, are recon-
mice. Nonetheless, it has been possible to demonstratestituted with limited numbers of B cells and fragment
increased tolerance susceptibility at a specific stage ofcultures derived from recipient spleens are stimulated
B cell maturation in most of these lines of immunoglobu-in vitro. Since the number of injected donor B cells can
lin transgenic mice. Unfortunately, each line of immuno-be limited so that each fragment contains 0 or 1 antigen-
globulin transgenic mice appears to be idiosyncraticandresponsive cell, antibody responses can be assessed
there is little agreement with respect to the maturationalat the clonal level and the frequency of responsive cells
stage at which the B cells of different Ig transgenic miceassessed (Klinman, 1972).
can be tolerized.The ability to stimulate fetal or neonatal B cells anti-
B cell development is truncated at the pre-B to B cellgenically was not only a prerequisite for testing their
transition and no sIg1 bone marrow cells are found intolerance susceptibility, but also, in and of itself, re-
mice that express transgene-encoded anti-double-quired a fundamental alteration of clonal selection pre-
stranded DNA antibodies (Chen et al., 1994). These find-cepts. The clonal selection theory did not anticipate that
ings are consistent with findings from mice chronicallycells passing through the maturational stage, wherein
treated with anti-immunoglobulin antibodies from birth,they were tolerance susceptible, could alternatively be
wherein no sIg1 bone marrow or peripheral B cells werestimulated under appropriate conditions (Metcalf and
observed (Lawton et al., 1972). These findings are alsoKlinman, 1976 1977). The surprising conclusionthat cells
consistent with the demonstration that over half of Bdid not pass through a tolerance-only maturational
cells expressing H chains encoded by the VH81X VH genestage was verified by studies of in vitro B cell develop-
segment, which are often self-reactive (Coutinho et al.,ment. In these studies, immature fetal B cells, which
1992), are eliminated during the pre-B to B cell transitionwere sufficiently immature as to be impervious to both
(Carlsson et al., 1992; Huetz et al., 1993; Decker et al.,tolerance induction and stimulation, entered a matura-
1995a).tional stage wherein they simultaneously became sus-
Although a population of sIgMlo bone marrow cellsceptible to both tolerance induction and stimulation
persists in the presence of tolerogen in other transgenic(Teale et al., 1979).
mouse models (Nemazee and Burki, 1989; Hartley et al.,B Cells Are Tolerance Susceptible During
1991, 1993) it is likely that the tolerance signal in cellsTwo Maturational Stages
of these mice is also delivered as sIg is first expressed.Although early studies of tolerance induction demon-
strated tolerance susceptibility of immature B cells, the The difference between these and the aforementioned
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studies, wherein no sIg1 cells could be found, may only Yellen et al., 1991; Scott, 1993) was not only unexpected
but surprisingly suggested that numerous B cells thatbe the extent to which sIgM expression is down-regu-
lated by the presence of environmental antigen. are specific for monovalent self-antigens would escape
tolerance. This introduced the concept that at leastIn contrast with these findings, B cell development in
mice expressing a transgene-encoded anti-2,4,6-trini- some self-reactive B cells would be present in the pe-
ripheral B cell pool and that other mechanisms wouldtrophenyl (TNP)-specific antibody, is truncated at a later
maturational stage and not until after sIgM and B220 be needed to ensure a lack of B cell responses to self-
antigens.are up-regulated (Carsetti et al., 1993, 1995). Tolerance
susceptibility at this transitional stage of bone marrow Monovalent antigens, exemplified by monovalent
hapten carrier complexes or free haptenic determinants,development may persist as bone marrow cells periph-
eralize and, thus, may play a role in the elimination of not only fail to induce the tolerance trigger but, to the
contrary, can act as antagonist to tolerance inductioncells recognizing self-antigens not present in the marrow
(peripheral tolerance) (Carsetti et al., 1995). Additional by occupying the sIg receptor binding sites (Metcalf and
Klinman, 1976; Teale and Klinman, 1980). This findingfindings with B cells expressing H chains encoded by
VH81X are consistent with a tolerance-susceptible stage convincingly contradicts the hypothesis that monova-
lent receptor engagement would induce the tolerancelate in bone marrow maturation, since there is a further
2-fold elimination of VH81X-expressing B cells at a late trigger (Bretcher and Cohn, 1970). Studies with
transgenic mice expressing anti-HEL antibodies initiallystage of bone marrow maturation and prior to entry of
cells into the spleen (Decker et al., 1995a). Tolerance suggested that monovalent antigens, in this case
transgene-encoded soluble HEL, could induce a formsusceptibility of transitional bone marrow cells has not
been observed in other immunoglobulin transgenic of partial tolerance, termed anergy (Nossal and Pike,
1980; Pike et al., 1982; Nossal, 1983; Goodnow et al.,mice; however, susceptibility at this stage would have
been missed if all B cells (which share receptors in 1988). Although the anti-HEL-expressing B cells under-
went a normal course of development in the presencetransgenic mice) were eliminated at an earlier matura-
tional stage. of soluble HEL, sIgM, but not sIgD, was down-regulated
on these cells; the cells were generally hyporesponsiveCell Surface Antigens Can Tolerize Mature
B Cells to antigenic stimulation; and these anergic cells did not
enter lymphoid follicles when normal cells were presentIn general, mature B cells are not susceptible to toler-
ance inductionby soluble antigenseither in vivo (Etlinger (Cyster et al., 1994). However, more careful studies with
these mice have demonstrated that some HEL polymersand Chiller, 1979; Klinman et al., 1981) or in vitro (Metcalf
and Klinman, 1976, 1977; Monroe, 1996). Exceptions to were present and may have been responsible for the
observed phenomena (Basten et al., 1991).this generalization are usually highly dependent on the
use of unique antigen conforms such as nondegradable The Tolerance Trigger Must Exceed
a Threshold Affinityantigens (Katz et al., 1971; Dintzis et al., 1989) or bioac-
tive molecules (Havas, 1969; Weigle et al., 1974; Borel A major concern of early theoreticians was the likelihood
that, given the vast array of self-antigenic determinantsand Kilham, 1974). A crucial exception, however, may
relate to antigens presented on cell surfaces. For exam- and the well-known tendency of antibodies to cross-
react with various antigens, if B cells were tolerized byple, antigenic determinants presented on erythrocytes
have been shown to tolerize mature peripheral B cells all self-antigens, the entire B cell repertoire would likely
be eliminated several times over (Mo¨ller et al., 1976).of conventional mice (Hamilton and Miller, 1974) and
CD51 cells of immunoglobulin transgenic mice (Oka- Indeed, if antigen concentrations are high, 1%–5% of
all B cells can be shown to bind to any of a variety ofmoto et al., 1992). Additionally, mature B cells of
transgenic mice expressing anti-class I major histocmo- antigens (Ada, 1970; Lawrence et al., 1973; Klinman et
al., 1976). However, most B cells that can bind an antigenpatibilty complex (MHC) antibody were tolerized when
transferred to mice expressing the cognate MHC mole- can neither be stimulated nor tolerized by that antigen,
even when the antigen is present at high concentrationscule (Russell et al., 1991). However, whether other cell–
cell interactions, such as the down-regulation of B cells (Klinman, 1972; Klinman et al., 1973, 1976, 1981; Teale
and Klinman, 1980). Thus, the triggering of B cells viathat recognize cell surface molecules of cytolytic T cells,
may play a role has yet to be determined (Bregenholt their sIg receptors appears to have an affinity threshold,
so that only those B cells with a relatively high affinityet al., 1996). Nonetheless these findings imply that inac-
tivation of B cells whose receptors interact with cell for a self-antigen would be eliminated. This would leave
much of the diverse repertoire intact, including B cellssurface antigens, may represent an important exception
to the correlation of tolerance susceptibility and B cell that recognize self-antigens but with low affinity.
Compelling evidence for an affinity threshold for toler-immaturity.
Tolerance Induction Requires sIg Receptor ance induction came from experiments that assessed
tolerance induction by homologous versus cross-reac-Cross-Linking
Early theories did not anticipate a requirement for sIg tive antigens (Teale and Klinman, 1980). In these studies,
it was demonstrated that, although 2,4-Dinitrtophenylreceptor interlinkage for tolerance induction (Jerne,
1955; Lederberg, 1959; Bretscher and Cohn, 1970). (DNP)-specific neonatal B cells were readily tolerized
by pretreatment with DNP–tolerogen (DNP complexedTherefore, the finding that only antigens that present
multiple copies of individual epitopes are capable of to a carrier not recognized by available Th), prior to
stimulation with DNP–immunogen (DNP complexed toinducing tolerance (Metcalf and Klinman, 1976; Teale
and Klinman, 1980; Klinman et al., 1981; Dintzis, 1989; the cognate carrier for Th) these cells were resistant
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to tolerance induction by the cross-reactive antigen (Hartley et al., 1993). The existence of a lag period
wherein tolerance induction is reversible, while not an-TNP. Importantly, if TNP–tolerogen was added to cul-
tures prior to the addition of DNP–tolerogen, the DNP- ticipated by the clonal selection hypothesis, is consis-
tent with findings from certain immunoglobulin trans-specific neonatal B cells remained responsive when
subsequently stimulated with DNP–immunogen. This in- genic mice that showed that the tolerance trigger may
induce cells to down-regulate their sIg and initiate fur-dicated that, while the multivalently presented low-affin-
ity ligand TNP could bind the sIg receptors of DNP- ther L chain rearrangement (Tiegs et al., 1993; Radic et
al., 1993). Such receptor editing, which would permitspecific B cells and, in so doing, antagonize the negative
selection of these cells by the high affinity ligand DNP, cells to express new non–anti-self sIg receptors, would
be dependent on the survival of cells after having re-TNP–tolerogen could not itself inactivate DNP-specific
B cells. Thus, although binding and cross-linking sIg ceived an initial tolerance signal.
The most dramatic and surprising example of the re-receptors of immature B cells is necessary for tolerance
induction, it is not sufficient unless the affinity of the versibility of tolerance induction is the capacity of Th
cell collaboration (Metcalf and Klinman, 1976, 1977) and,interaction exceeds a minimal threshold. These findings
are reminiscent of current considerations of the affinity in some instances, mitogenic stimulation (reviewed by
Weigle, 1980) to abrogate tolerance and, instead, leaddependence of agonist and antagonist peptides in the
positive and negative selection of developing thymic to the generation of AFC clones. To date, all instances
wherein immature bone marrow or neonatal splenic BT cells (Sette et al., 1994; Jameson and Bevan, 1995;
Germain et al., 1995). As with the findings for T cells, the cells, and newly generating memory B cells (see below),
have been shown to be susceptible to tolerance induc-affinity dependence of the interaction was interpreted
as implying a need to maintain stable complexes of tion by hapten presented multivalently on a carrier not
recognized by available Th, the same cells could beinterlinked receptors to enable triggering and a destabili-
zation of these complexes by lower affinity for antago- stimulated by hapten on a carrier that was recognized
by Th (Metcalf and Klinman, 1976, 1977; Linton et al.,nists (Klinman, 1972; Teale and Klinman, 1980; Dintzis
et al., 1989). 1991).
Consistent with these findings are the results of recentThe affinity dependence of tolerance induction was
also demonstrated for other haptens. Indeed, it was studies wherein tolerance induction of suspension cul-
tures of immature B cells by anti-immunoglobulin anti-possible to demonstrate that tolerance induction re-
quired a higher affinity of interaction than that required bodies was reversed by the addition of interleukin-4
(Monroe, 1996). Thus, consistent with the predictionfor stimulation (Riley and Klinman, 1986). However, re-
cent findings from immunoglobulin transgenic mice that, whereas one signal, in this case that resulting from
stable sIg receptor interlinkage, induced tolerance, ahave suggested that, at least for cells reactive to class
I MHC molecules, relatively low affinity ligands may in- second signal, in this case derived from Th, induces
stimulation. However, this scenario is applicable only toduce tolerance (Russell et al., 1991). However, as dis-
cussed above, when B cell receptors interact with anti- immature B cells, since mature B cells that receive only
one signal are not inactivated.gens on the surface of another cell, numerous cell–cell
interactions are likely to occur, which may obviate much Newly Generating Memory B Cells Are
Tolerance Susceptibleof the affinity requisites of the sIg receptor interaction
per se or inactivate B cells by other means. Although it was suggested as a tenet of the clonal selec-
tion hypothesis that initial repertoire diversity might re-If the affinity threshold for tolerance for soluble anti-
gens is high and can even exceed the affinity needed sult from the somatic mutation of genes encoding sIg
receptors (Burnet, 1957, 1959; Lederberg, 1959), thefor stimulation, it would be anticipated that some B cells
that could potentially respond to self-antigens may be postulates also assumed that, once generated, there
would be “a phase in which the randomly developedpresent in the mature peripheral B cell pool. Indeed,
there are several instances wherein mature B cells reac- specification is stabilized and transferred as such to
descendent cells and at this stage any clones of cellstive to self-antigens have been demonstrated (Mo¨ller et
al., 1976; Weigle, 1980; Harris et al., 1982; Stockinger which carry reactive sites corresponding to body deter-
minants will be eliminated” (Burnet, 1957). As currentlyand Hausmann, 1988). In one instance, the affinity of
antibodies generated against a self-antigen was as- understood, in mice and man somatic mutation primarily
plays a role in the generation of memory rather thansessed and shown to be lower than that generated
against a similar nonself-antigen (Cooper et al., 1988). naive B cells (Clarke et al., 1985; Manser et al., 1987;
Berek and Milstein, 1987; Malipiero et al., 1987; Rajew-B Cell Tolerance Can Be Reversed
Studies of both tolerance induction of neonatal B cells sky et al., 1987). Thus, although the initially diversified
naive repertoire does stabilize and is purged of anti-selfin fragment culture (Metcalf and Klinman, 1976) and
immunoglobulin transgenic mice (Hartley et al., 1993) recognition, specificities can be destabilized by somatic
hypermutation during the course of memory B cell gen-have indicated that the tolerance trigger is time depen-
dent and can be reversed by early antigen removal. In eration following antigenic stimulation. This second
course of diversification of antigen-stimulated cellsthe case of DNP-specific neonatal B cells, most B cells
remained reactive if tolerogen was removed after 2 hr plays an important role in affinity maturation (Clarke et
al., 1985; Berek and Milstein, 1987; Manser et al., 1987;and about half remained reactive if tolerogen was re-
moved after 6 hr (Metcalf and Klinman, 1976). In the Rajewsky et al., 1987). However, it can potentially also
generate novel anti-self specificities, thus requiring acase of immunoglobulin transgenic mice, bone marrow
B cells removed from the host environment could un- second “window” of tolerance susceptibility unantici-
pated by early theoreticians (Linton et al., 1991).dergo development in the absence of antigen in vitro
Minireview
193
Memory B cell generation takes place primarily in ger- nor those that recognize antigens that present determi-
nants monovalently are eliminated. Additionally, T cellminal centers (GCs) within the secondary follicles of
peripheral lymphoid tissues (Coico et al., 1983; Nieu- help can circumvent B cell tolerance. Even though T cell
help would rarely be available in the adult bone marrowwenhuis et al., 1992; Berek, 1992). In recent years, it has
been possible to assess memory B cell generation by or neonatal spleen, in some instances B cells might
escape tolerance by receiving T cell or mitogenic sig-the microsectioning and analysis of GCs generated in
the spleen or lymph nodes of immunized mice (Jacob nals. This would not be trivial during the generation of
memory B cells wherein T cell help would likely be avail-et al., 1991; Berek, 1992). Additionally, memory B cells
have been generated in vitro throughthe use of fragment able. Thus, for newly generating memory B cells whose
V region mutations create anti-self reactivity, the fate ofcultures supplemented with nonirradiated Th, which
presumably maintain sufficient tissue architecture and the cells could depend on a competition for receptors
by self-antigen, for which Th would not be available,cell–cell interactions to enable memory cell generation
and the accumulation of somatic mutations (Linton et and the immunizing antigen, wherein Th and positive
selection would be available (Linton et al., 1991).al., 1989; Decker et al., 1995b; Klinman, 1996). Findings
from fragment culture analyses of memory Bcell genera- As a result of these exceptions to clonal selection
expectations, and the absence of some self-antigenstion demonstrated that, although prior to stimulation
naive progenitors of memory B cells are resistant to from the bone marrow, many self-reactive B cells are
present in the peripheral B cell pool (Mo¨ller et al., 1976;tolerance induction, following stimulation the newly gen-
erating clonal progeny of these cells rapidly become Harris et al., 1982; Cooper et al., 1988; Stockinger and
Hausmann, 1988). Although, in some instances, thetolerance susceptible (Linton et al., 1991). The parame-
ters of tolerance susceptibility of newly generating presence of such B cells may enable auto-antibody pro-
duction, the systemic immune system has several safe-memory B cells were shown to be similar to those found
for immature bone marrow and neonatal B cells in that guards. Most important, stimulation by most antigens
requires Th, and Th specific for self-antigens are rare.receptor interlinkage was required and tolerance could
be reversed by T cell help. However, the affinity requisite Additionally, several safeguards appear to be built into
the B cell tolerance mechanism per se. First, as de-for tolerance induction of newly generating memory B
cells was apparently lower than that of newly generating scribed above, many anti-self antibodies would exhibit
low affinity for self-antigens whether the B cells werenaive B cells, since TNP–tolerogen complexes inacti-
vated most DNP-specific memory B cell clones. Recent stimulated by a cross-reactive foreign antigen or the
self-antigen. Second, there is a second window of toler-in vivo analyses of GC cells of both conventional and
immunoglobulin transgenic mice have confirmed the tol- ance susceptibility that prohibits the generation of anti-
self memory B cells. This eliminates the possibility oferance susceptibility of newly generating memory B
cells and have shown a marked increase in apoptotic either expanded clones of anti-self B cells or the genera-
tion of high affinity anti-self B cells. Indeed, it appearscells in GCs of mice that were immunized and subse-
quently injected with tolerogens (Pulendran et al., 1995; that a breakdown in this mechanism may be responsible
for much of autoimmune disease (Radic et al., 1989).Shokat and Goodnow, 1995).
Third, there are modes of B cell innactivation, such as
anergy, that may be applicable to more mature B cells
Conclusion that may disfavor B cell longevity or stimulation and
The fundamental precepts of the clonal selection hy- thus may supplement the tolerance mechanisms that
pothesis have stood well the test of four decades of eliminate newly generating anti-self cells. Finally, certain
subsequent research. Thus, self–nonself-discrimination antigenic determinants, such as those present on cell
does, as predicted, rely on the unipotentiality of B cells surfaces, may lead to the elimination of even mature B
and the eliminationof self-reactive B cells as they mature cells, thus ensuring a lack of reactivity to certain crucial
via signals induced through the sIg receptors of the self-components. Therefore, although the mechanisms
cells. Furthermore, many of the logical extensions of that are available to ensure the absence of auto-anti-
this theory have been confirmed. For example, if toler- body production are far more complex than anticipated
ance were to apply to the spectrum of self-antigens, by the clonal selection hypothesis, the absence from
tolerance induction of immature B cells should ideally the repertoire of mature B cells with the capacity to
be applicable to an array of self-antigenic structures respond to self-constituents and generate high affinity
over a broad concentration range. Indeed, tolerance auto-antibodies is precisely the predicted outcome of
induction of immature B cells can be induced even by the theory.
extremely low concentrations of antigen and appears
to be independent of the form of the antigen (Metcalf
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